Blend Labs (BLND) Head of Revenue sells 15,041 shares in 10b5-1 trade

Rhea-AI Filing Summary

Blend Labs, Inc. reported that Head of Revenue Matthew Christopher Thomson sold 15,041 shares of Class A Common Stock on August 5, 2026 at a weighted average price of $2.004 per share, within a $2.00 to $2.005 range, in a sale reported as open market or private.

After this transaction, Thomson directly holds 60,162 shares. The sale was effected under a Rule 10b5-1 trading plan adopted on March 16, 2026.

Insider Trade Summary 10b5-1

Net Seller: 15,041 shares

Net Sell 1 txn

Insider Thomson Matthew Christopher

Role Head of Revenue

Sold 15,041 shs ($30K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2	15,041	$2.004	$30K

Holdings After Transaction: Class A Common Stock — 60,162 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2026.
2. F2. This sale price represents the weighted average sale price of the shares sold ranging from $2.00 to $2.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Key Figures

Shares sold: 15,041 shares Weighted average sale price: $2.004 per share Shares held after transaction: 60,162 shares +1 more

4 metrics

Shares sold 15,041 shares Class A Common Stock sold on August 5, 2026

Weighted average sale price $2.004 per share Weighted average within a $2.00 to $2.005 per-share range

Shares held after transaction 60,162 shares Direct holdings of Class A Common Stock following the sale

10b5-1 plan adoption date March 16, 2026 Adoption date of the Rule 10b5-1 trading plan governing this sale

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, Class A Common Stock

3 terms

Rule 10b5-1 trading plan financial

"The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"This sale price represents the weighted average sale price of the shares sold."

Class A Common Stock financial

"Security title reported as Class A Common Stock in the insider transaction."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 04:05 PM Accepted by SEC EDGAR 08/07/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What insider stock sale did Blend Labs (BLND) disclose for Matthew Christopher Thomson?

Blend Labs disclosed that Head of Revenue Matthew Christopher Thomson sold 15,041 shares of Class A Common Stock. The August 5, 2026 transaction was reported at a weighted average price of $2.004 per share, under a pre-established Rule 10b5-1 trading plan.

Was the recent Blend Labs (BLND) insider sale made under a Rule 10b5-1 plan?

Yes, the reported sale was effected under a Rule 10b5-1 trading plan adopted on March 16, 2026. This plan-based structure means the trade followed pre-set instructions rather than being initiated at the insider’s discretion at the time of sale.

How many Blend Labs (BLND) shares does Matthew Christopher Thomson hold after the sale?

Following the transaction, Matthew Christopher Thomson directly holds 60,162 shares of Blend Labs Class A Common Stock. This figure reflects his position immediately after selling 15,041 shares in the August 5, 2026 transaction disclosed in the insider report.

What price range applied to the Blend Labs (BLND) shares sold in this insider trade?

The reported weighted average sale price was $2.004 per share, with individual trades ranging from $2.00 to $2.005. The insider stated willingness to provide detailed breakdowns of share counts at each separate price upon appropriate request.

What role does Matthew Christopher Thomson hold at Blend Labs (BLND) in this insider filing?

The reporting person, Matthew Christopher Thomson, serves as Blend Labs’ Head of Revenue, an executive officer role. His position is noted in the insider report, which details his direct ownership and the August 5, 2026 sale of Class A Common Stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomson Matthew Christopher

(Last) (First) (Middle)

7250 REDWOOD BLVD., SUITE 300

(Street)

NOVATO CALIFORNIA 94945

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Blend Labs, Inc. [ BLND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Head of Revenue

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/05/2026		S(1)		15,041	D	$2.004(2)	60,162	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2026.

2. This sale price represents the weighted average sale price of the shares sold ranging from $2.00 to $2.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Kostian Ciko, Attorney-in-fact	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)